A.S.P.E.N. Clinical Guidelines: Support of Pediatric Patients with Intestinal Failure at Risk of Parenteral Nutrition-Associated Liver Disease

Journal of Parenteral and Enteral Nutrition

Volumn 38, Issue 5, 2014, Pages 538-557

  Wales, Paul W ^a,b   Allen, Nancy ^c   Worthington, Patricia ^d   George, Donald ^e   Compher, Charlene ^f   Teitelbaum, Daniel ^g  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^e NEMOURS CHILDREN S CLINIC   (United States)

^f UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^g UNIVERSITY OF MICHIGAN   (United States)

Author keywords

home nutrition support; life cycle; lipids; nutrition; parenteral nutrition; pediatrics

Indexed keywords

LIPID EMULSION; URSODEOXYCHOLIC ACID;

ARTICLE; BLOODSTREAM INFECTION; CATHETER REMOVAL; CHILD CARE; CHILDHOOD DISEASE; DISEASE ASSOCIATION; ENTERIC FEEDING; HUMAN; INTESTINAL FAILURE; INTRAVENOUS CATHETER; LIVER DISEASE; OBSERVATIONAL STUDY; PARENTERAL NUTRITION; PARENTERAL NUTRITION ASSOCIATED LIVER DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC);

EID: 84904752293     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607114527772     Document Type: Article

References (71)

1. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005 ; 40 (5). 755-762 (Pubitemid 40724842)
2. Nucci A, Burns RC, Armah T, et al. Interdisciplinary management of pediatric intestinal failure: a 10-year review of rehabilitation and transplantation. J Gastrointest Surg. 2008 ; 12 (3). 429-436
3. Torres C, Sudan D, Vanderhoof J, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr. 2007 ; 45 (2). 204-212 (Pubitemid 47220529)
4. Diamond IR, de Silva N, Pencharz PB, et al. Neonatal short bowel syndrome outcomes after the establishment of the first Canadian multidisciplinary intestinal rehabilitation program: preliminary experience. J Pediatr Surg. 2007 ; 42 (5). 806-811 (Pubitemid 46719214)
5. Modi BP, Langer M, Ching YA, et al. Improved survival in a multidisciplinary short bowel syndrome program. J Pediatr Surg. 2008 ; 43 (1). 20-24
6. Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009 ; 19 (6). 348-353
7. Diamond IR, Pencharz PB, Feldman BM, Ling SC, Moore AM, Wales PW. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease. Arch Pediatr Adolesc Med. 2012 ; 166 (5). 473-478
8. Rangel SJ, Calkins CM, Cowles RA, et al. Parenteral nutrition-associated cholestasis: an American Pediatric Surgical Association Outcomes and Clinical Trials Committee systematic review. J Pediatr Surg. 2012 ; 47 (1). 225-240
9. Diamond IR, de Silva NT, Tomlinson GA, et al. The role of parenteral lipids in the development of advanced intestinal failure-associated liver disease in infants: a multiple-variable analysis. JPEN J Parenter Enteral Nutr. 2011 ; 35 (5). 596-602
10. Mutanen A, Lohi J, Heikkile P, Koivusalo AI, Rintala RJ, Pakarinen MP. Persistent abnormal liver fibrosis after weaning off parenteral nutrition in pediatric intestinal failure. Hepatology. 2013 ; 58: 729-738
11. Piper HG, Wales PW. Prevention of catheter-related blood stream infections in children with intestinal failure. Curr Opin Gastroenterol. 2013 ; 29 (1). 1-6
12. Sanders J, Pithie A, Ganly P, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother. 2008 ; 62 (4). 809-815
13. Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J Infect. 2004 ; 49 (1). 20-22 (Pubitemid 38950243)
14. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000 ; 132: 525-532 (Pubitemid 30171891)
15. Cober MP, Kovacevich DS, Teitelbaum DH. Ethanol-lock therapy for the prevention of central venous access device infections in pediatric patients with intestinal failure. JPEN J Parenter Enteral Nutr. 2011 ; 35 (1). 67-73
16. Rollins MD, Ward RM, Jackson WD, et al. Effect of decreased parenteral soybean lipid emulsion on hepatic function in infants at risk for parenteral nutrition-associated liver disease: a pilot study. J Pediatr Surg. 2013 ; 48 (6). 1348-1356
17. San Luis VA, Btaiche IF. Ursodiol in patients with parenteral nutrition-associated cholestasis. Ann Pharmacother. 2007 ; 41 (11). 1867-1872 (Pubitemid 350044350)
18. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002 ; 26 (1). 1SA - 138SA
19. Arsenault D, Brenn M, Kim S, et al. A.S.P.E.N. Clinical Guidelines: hyperglycemia and hypoglycemia in the neonate receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 2012 ; 36 (1). 81-95
20. Fallon EM, Nehra D, Potemkin AK, et al. A.S.P.E.N. Clinical Guidelines: nutrition support of neonatal patients at risk for necrotizing enterocolitis. JPEN J Parenter Enteral Nutr. 2012 ; 36 (5). 506-523
21. McMahon MM, Nystrom E, Braunschweig C, et al. A.S.P.E.N. Clinical Guidelines: nutrition support of adult patients with hyperglycemia. JPEN J Parenter Enteral Nutr. 2013 ; 37 (1). 23-36
22. Mehta NM, Compher C. A.S.P.E.N. Clinical Guidelines: nutrition support of the critically ill child. JPEN J Parenter Enteral Nutr. 2009 ; 33 (3). 260-276
23. Mueller C, Compher C, Ellen DM. A.S.P.E.N. Clinical Guidelines: nutrition screening, assessment, and intervention in adults. JPEN J Parenter Enteral Nutr. 2011 ; 35 (1). 16-24
24. Brown RO, Compher C. A.S.P.E.N. Clinical Guidelines: nutrition support in adult acute and chronic renal failure. JPEN J Parenter Enteral Nutr. 2010 ; 34 (4). 366-377
25. Jaksic T, Hull MA, Modi BP, Ching YA, George D, Compher C. A.S.P.E.N. Clinical Guidelines: nutrition support of neonates supported with extracorporeal membrane oxygenation. JPEN J Parenter Enteral Nutr. 2010 ; 34 (3). 247-253
26. Jesuit C, Dillon C, Compher C. Lenders CM. A.S.P.E.N. Clinical Guidelines: nutrition support of hospitalized pediatric patients with obesity. JPEN J Parenter Enteral Nutr. 2010 ; 34 (1). 13-20
27. August DA, Huhmann MB. A.S.P.E.N. Clinical Guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr. 2009 ; 33 (5). 472-500
28. Sabery N, Duggan C. A.S.P.E.N. Clinical Guidelines: nutrition support of children with human immunodeficiency virus infection. JPEN J Parenter Enteral Nutr. 2009 ; 33 (6). 588-606
29. SchunemannHBrozekJOxmanAD. GRADE handbook for grading quality of evidence and strength of recommendation. Version 3.2. 2009. http://www.cc-ims.net/ gradepro. Accessed September 27, 2013.
30. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011 ; 64 (4). 383-394
31. Guyatt GH, Oxman AD, Kunz R, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011 ; 64 (4). 395-400
32. Guyatt GH, Oxman AD, Vist G, et al. GRADE guidelines: 4. Rating the quality of evidence - study limitations (risk of bias). J Clin Epidemiol. 2011 ; 64 (4). 407-415
33. Druyan ME, Compher C, Boullata JI, et al. Clinical guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients: applying the GRADE system to development of A.S.P.E.N. clinical guidelines. JPEN J Parenter Enteral Nutr. 2012 ; 36 (1). 77-80
34. Oliveira C, Nasr A, Brindle M, Wales PW. Ethanol locks to prevent catheter-related bloodstream infections in parenteral nutrition: a meta-analysis. Pediatrics. 2012 ; 129 (2). 318-329
35. Crnich C, Halfmann J, Crone W, Maki DG. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol. 2005 ; 26: 708-714 (Pubitemid 41169741)
36. Cober MP, Johnson CE. Stability of 70% alcohol solutions in polypropylene syringes for use in ethanol-lock therapy. Am J Health System Pharm. 2007 ; 64 (23). 2480-2482 (Pubitemid 350209838)
37. Food and Drug Administration. 2013. http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm370740.htm
38. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000 ; 24 (6). 345-350
39. Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome. Nutr Clin Pract. 2010 ; 25 (2). 199-204
40. Shin JI, Namgung R, Park MS, Lee C. Could lipid infusion be a risk for parenteral nutrition-associated cholestasis in low birth weight neonates?. Eur J Pediatr. 2008 ; 167 (2). 197-202
41. Cober MP, Killu G, Brattain A, Welch KB, Kunisaki SM, Teitelbaum DH. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr. 2012 ; 160 (3). 421-427
42. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121 (3). e678 - e686
43. Le HD, de Meijer VE, Robinson EM, et al. Parenteral fish-oil-based lipid emulsion improves fatty acid profiles and lipids in parenteral nutrition-dependent children. Am J Clin Nutr. 2011 ; 94 (3). 749-758
44. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250 (3). 395-402
45. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 ; 33 (5). 541-547
46. Goulet O, Antebi H, Wolf C, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010 ; 34 (5). 485-495
47. Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of omega-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010 ; 64 (9). 940-947
48. Tomsits E, Pataki M, Tolgyesi A, Fekete G, Rischak K, Szollar L. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010 ; 51 (4). 514-521
49. Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012 ; 36 (1). 81S - 94S
50. Heubi JE, Wiechmann DA, Creutzinger V, et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr. 2002 ; 141 (2). 237-242
51. Al-Hathlol K, Al-Madani A, Al-Saif S, Abulaimoun B, Al-Tawil K, El-Demerdash A. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants. Singapore Med J. 2006 ; 47 (2). 147-151 (Pubitemid 43189383)
52. Stanger JD, Oliveira C, Blackmore C, Avitzur Y, Wales PW. The impact of multi-disciplinary intestinal rehabilitation programs on the outcome of pediatric patients with intestinal failure: a systematic review and meta-analysis. J Pediatr Surg. 2013 ; 48 (5). 983-992
53. Pieroni KP, Nespor C, Ng M, et al. Evaluation of ethanol lock therapy in pediatric patients on long-term parenteral nutrition. Nutr Clin Pract. 2013 ; 28 (2). 226-231
54. Wong T, Clifford V, McCallum Z, et al. Central venous catheter thrombosis associated with 70% ethanol locks in pediatric intestinal failure patients on home parenteral nutrition: a case series. JPEN J Parenter Enteral Nutr. 2012 ; 36 (3). 358-360
55. Wales PW, Kosar C, Carricato M, de Silva N, Lang K, Avitzur Y. Ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients with intestinal failure: preliminary experience. J Pediatr Surg. 2011 ; 46 (5). 951-956
56. Jones BA, Hull MA, Richardson DS, et al. Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure. J Pediatr Surg. 2010 ; 45 (6). 1287-1293
57. Mouw E, Chessman K, Lesher A, Tagge E. Use of an ethanol lock to prevent catheter-related infections in children with short bowel syndrome. J Pediatr Surg. 2008 ; 43 (6). 1025-1029 (Pubitemid 351814902)
58. Nehra D, Fallon EM, Carlson SJ, et al. Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr. 2013 ; 37 (4). 498-505
59. Calkins KL, Dunn JC, Shew SB, et al. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil [published online July 26, 2013]. JPEN J Parenter Enteral Nutr. :
60. Premkumar MH, Carter BA, Hawthorne KM, King K, Abrams SA. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr Endocrinol Metabol. 2013 ; 162: 793-798
61. Le HD, Gura KM, Arsenault DA, Fallon EM, Potemkin AK, Puder M. Assessing portal fibrosis in parenteral nutrition-dependent patients treated with omega-3 fatty acid lipid emulsion. J Pediatr. 2010 ; 157 (3). 517-518
62. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg. 2010 ; 145 (6). 547-551
63. Diamond IR, Pencharz PB, Wales PW. Omega-3 lipids for intestinal failure associated liver disease. Semin Pediatr Surg. 2009 ; 18 (4). 239-245
64. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009 ; 66 (6). 698-703
65. Le HD, de Meijer VE, Zurakowski D, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy improves lipid profiles in children with parenteral nutrition-associated liver disease. JPEN J Parenter Enteral Nutr. 2010 ; 34 (5). 477-484
66. de Meijer VE, Le HD, Meisel JA, Gura KM, Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr. 2010 ; 50 (2). 212-218
67. Gokmen T, Oguz SS, Bozdag S, Erdeve O, Uras N, Gilmen U. A controlled trial of erythromycin and UDCA in premature infants during parenteral nutrition in minimizing feeding intolerance and liver function abnormalities. J Perinatol. 2012 ; 32: 123-128
68. Arslanoglu S, Moro GE, Tauschel HD, Boehm G. Ursodeoxycholic acid treatment in preterm infants: a pilot study for the prevention of cholestasis associated with total parenteral nutrition. J Pediatr Gastroenterol Nutr. 2008 ; 46 (2). 228-231 (Pubitemid 351161137)
69. De Marco G, Sordino D, Bruzzesi E, et al. Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure. Aliment Pharmacol Ther. 2006 ; 24: 387-394 (Pubitemid 43972907)
70. Chen C-Y, Tsao P-N, Chen HL, et al. Ursodeoxycholic acid therapy in very low birth weight infants with parenteral nutrition-associated cholestasis. J Pediatr. 2004 ; 2004 (145). 317-321 (Pubitemid 39165678)
71. Spagnuolo MI, Iorio R, Vegnente A, Guarino A. Ursodeoxycholic acid for treatment of cholestasis in children on long-term total parenteral nutrition: a pilot study. Gastroenterology. 1996 ; 111 (3). 716-719 (Pubitemid 26293237)